What is true about Tuberculoid leprosy (also known as Paucibacillary leprosy)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Characteristics of Tuberculoid Leprosy

  • Tuberculoid leprosy is characterized by cutaneous lesions called plaques 1
  • It is also known as Paucibacillary leprosy, indicating a lower bacterial load compared to Multibacillary leprosy 2, 3
  • The disease is marked by a strong Th1-type cell response with localized lesions 3, 4
  • Granuloma-activated macrophages kill Mycobacterium leprae in conjunction with a Th1 response 2, 4

Clinical Presentation

  • Tuberculoid leprosy presents with well-demarcated granulomas, infiltrated by CD4+ T lymphocytes, containing epitheloid and multinucleated giant cells 4
  • The clinical presentation is characterized by asymmetric skin lesions with sensory loss, but without peripheral nerve involvement in some cases 5
  • The disease can occur in patients with other underlying conditions, such as childhood-onset systemic lupus erythematosus (c-SLE) 5

Immune Response

  • The immune response in tuberculoid leprosy is characterized by the production of IFN-γ and IL-2, which activates macrophages to kill intracellular pathogens 3, 4
  • The Th1 response is dominant in tuberculoid leprosy, whereas a Th2 response is characteristic of lepromatous leprosy 3, 4
  • Regulatory T cells, such as Treg and natural killer T cells, play a crucial role in deciding the polarized state of T cell immunity in leprosy 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.